These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3541069)

  • 41. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
    Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [High-dose therapy followed by auto HSCT in children--with advanced neuroblastoma in four transplant centres in Poland].
    Zaucha-Prazmo A; Drabko K; Wójcik B; Choma M; Kałwak K; Gorczyńska E; Turkiewicz D; Słociak M; Ussowicz M; Dyla A; Chybicka A; Goździk J; Ratajczak M; Styczyński J; Debski R; Wysocki M; Kowalczyk J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):775-84. PubMed ID: 17317908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
    Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
    Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.
    Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N
    J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Autologous bone marrow transplantation in the treatment of children with neuroblastoma; 30 patients in 10 years].
    de Kraker J; Boon F; van Leeuwen EF; Voûte PA
    Ned Tijdschr Geneeskd; 1994 Oct; 138(42):2097-100. PubMed ID: 7969576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma].
    Philip T; Zucker JM; Bernard JL; Bordigoni P; Souillet G; Robert A; Roche H; Philip I; Chauvin F; Favrot MC
    Bull Cancer; 1988; 75(1):113-7. PubMed ID: 3282573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experience of multimodal therapy for advanced neuroblastoma].
    Iwata M; Okabe I; Koshinaga T; Hagino N; Morita K; Mugishima H; Kamata R
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1163-6. PubMed ID: 1944178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemo-radiotherapy and autologous bone marrow transplantation in poor prognosis neuroblastoma.
    Franzone P; Scarpati D; Vitale V; Corvó R; Barra S; Guenzi M; Orsatti M; Dini G
    Radiother Oncol; 1990; 18 Suppl 1():102-4. PubMed ID: 2247630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
    Dini G; Lanino E; Garaventa A; Rogers D; Dallorso S; Viscoli C; Castagnola E; Manno G; Brisigotti M; Rosanda C
    J Clin Oncol; 1991 Jun; 9(6):962-9. PubMed ID: 2033431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.
    August CS; Serota FT; Koch PA; Burkey E; Schlesinger H; Elkins WL; Evans AE; D'Angio GJ
    J Clin Oncol; 1984 Jun; 2(6):609-16. PubMed ID: 6374056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
    Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
    Bone Marrow Transplant; 1991; 7 Suppl 2():92. PubMed ID: 1878740
    [No Abstract]   [Full Text] [Related]  

  • 56. Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
    Zucker JM; Philip T; Bernard JL; Michon J; Bouffet E; Gentet JC; Lopez M; Coze C; Philip I; Bordigoni P
    Prog Clin Biol Res; 1991; 366():543-51. PubMed ID: 2068171
    [No Abstract]   [Full Text] [Related]  

  • 57. Comprehensive treatment of advanced neuroblastoma involving autologous bone marrow transplant.
    Mugishima H; Harada K; Suzuki T; Chin M; Shimada T; Takamura M; Shichino H; Fujisawa T; Ichikawa M; Iwata M
    Acta Paediatr Jpn; 1995 Aug; 37(4):493-9. PubMed ID: 7572151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma.
    Nève V; Foot AB; Michon J; Fourquet A; Zucker JM; Boulé M
    Med Pediatr Oncol; 1999 Mar; 32(3):170-6. PubMed ID: 10064183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.
    Pole JG; Casper J; Elfenbein G; Gee A; Gross S; Janssen W; Koch P; Marcus R; Pick T; Shuster J
    J Clin Oncol; 1991 Jan; 9(1):152-8. PubMed ID: 1985165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma.
    Gordon SJ; Pearson AD; Reid MM; Craft AW
    Eur J Cancer; 1992; 28A(8-9):1319-23. PubMed ID: 1515242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.